Despite increasing recognition of misophonia, there are currently no evidence-based treatments to help those who are suffering. Therefore, the primary purpose of this study is to assess the acceptability, feasibility, and preliminary efficacy of a treatment for misophonia. This study will be conducted in two phases. In the Phase 1, participants will receive a treatment the investigators believe can help manage symptoms of misophonia: The Unified Protocol. This treatment uses evidence-based psychological principles (e.g., managing attention or behavior) in a flexible manner and will focus on developing skills to help reduce the distress and impairment associated with Misophonia. After treatment, patients will provide feedback about their experience. The investigators will use this feedback to revise the treatment as indicated. In Phase 2, participants will receive the revised treatment and provide feedback on their experience. Throughout treatment in either phase, participants will provide daily and weekly information about their symptoms. The aims of this study are (1) to explore the acceptability and feasibility of the Unified Protocol for individuals who experience Misophonia and (2) to examine whether this treatment helps reduce symptoms associated with Misophonia.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Number of patients that are satisfied with treatment as measured by the credibility and expectancy questionnaire (CEQ
Timeframe: up to 20 weeks
Number of patients who indicate treatment was acceptable to them (i.e., the treatment approach made sense and was perceived as reasonable)
Timeframe: up to 20 weeks
Number of sessions attended
Timeframe: up to 20 weeks
Number of patients who use mindfulness skills assessed by the Southampton Mindfulness Questionnaire (SMQ)
Timeframe: up to 24 weeks
Number of patients who use cognitive flexibility skills assessed by the UP Cognitive Skills Questionnaire (CSQ)
Timeframe: up to 24 weeks
Number of Patients who use behavior change skills assessed by the UP Behavioral Avoidance Questionnaire (BAQ)
Timeframe: up to 24 weeks
Number of patients who report a decrease in anxiety sensitivity on the Anxiety Sensitivity Index (ASI)
Timeframe: up to 24 weeks
Number of Patients who use behavior change skills assessed by the Brief Experiential Avoidance Questionnaire (BEAQ)
Timeframe: up to 24 weeks
Change in misophonia symptoms as assessed by the Misophonia Questionnaire
Timeframe: assessed weekly, up to 24 weeks
Change in anxiety as measured by the Overall Anxiety Severity and Impairment Scale
Timeframe: assessed weekly, up to 24 weeks
Change in depression as measured by the Overall Depression Severity and Impairment Scale
Timeframe: assessed weekly, up to 24 weeks
Change in anger as measured by the PANAS Hostility Scale
Timeframe: assessed weekly, up to 24 weeks